Benzinga | Jan 28, 2022 09:25AM EST

Deutsche Bank Downgrades Quest Diagnostics to Hold, Announces $129 Price Target

Deutsche Bank analyst Pito Chickering downgrades Quest Diagnostics (NYSE:DGX) from Buy to Hold and announces $129 price target.